Immunodiagnostic Systems Holdings PLC (LSE:IDH) - Overview

Stock Report

Immunodiagnostic Systems Holdings PLC IDH

Last Price
GBX200.00

Day Change
-2.50|-1.23%

As of 08/12/2016
08:48:02 GMT | GBX
Minimum 15 Minutes Delay.

Last Close202.50p
Day Range200.00 - 200.00
Mkt Cap59.56Mil
52-Wk Range110.00 - 258.00
Yield %1.50
ISINGB00B01YZ052
Volume5,000
P/E8.94
P/S1.53
P/CF7.11

Share Price

Total Returns 07/12/2016

 Chg (%)  
More ...
Immunodiagnostic Systems Holdings PLC14.08 
FTSE 100 TR GBP1.82
 
Financials
201420152016
More ...
Income Statement
Turnover52.2645.3638.31
Operating Profit8.263.27-36.80
Net Profit6.952.35-32.17
Reported EPS23.708.00-109.70
Balance Sheet
Current Assets42.5440.5543.18
Non Current Assets59.9256.5519.16
Total Assets102.4697.1062.34
Current Liabilities7.767.196.55
Total Liabilities15.8816.6910.74
Total Equity86.5980.4151.60
Cash Flow
Operating Cash Flow13.828.948.09
Net Change in Cash7.23-2.442.38
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017-8.50-62.0123.82-0.38--
2018-9.107.0622.253.15--
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
08/07/2016PurchasePeter Kaspar142.004,1005,822.00
01/07/2016PurchasePeter Kaspar138.005,0006,900.00
30/06/2016PurchasePeter Kaspar136.506,0008,190.00
27/06/2016PurchasePatricio Lacalle Zando136.4717,25823,551.00

Company Profile

Immunodiagnostic Systems Holdings PLC is engaged in the manufacturing and distributing medical diagnostic products. It is also involved in research and development projects.
 

Sector

Medical Devices

Market Position

1031 of 1865 Companies

Index

FTSE AIM All Share

Outlook

(25/11/2016) no outlook statement

Next Event 31/03/2017

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)22.7216.8115.86
Div Yld (E)0.001.984.26
PEG (E)-0.741.560.15
ROCE3.7032.63-30.49
Op Mrgn4.07-23.29-33.54
EPS Grwth-30.5515.8723.13
Dividends
PreviousLatest
More ...
Record Date24/07/1522/07/16
Ex-Div23/07/1521/07/16
Paid21/08/1519/08/16
Amnt3.001.20

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanDr Burkhard Wittek
Chief Executive OfficerPatricio Lacalle Zando
Chief Financial Officer & Company SecretPaul Martin
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.